Abstract
This experiment was aimed at exploring the role of endogenous neurotensin in the development of sensitization to the locomotor stimulant effect of morphine. During the induction phase (Days 1, 3, 5 and 7), male Long-Evans adult rats were treated with the neurotensin antagonist SR-48692 (160, 320 or 640 microg/kg, i.p.) or its vehicle, followed by morphine (5.0 mg/kg, i.p.) or its vehicle, and their locomotor activity (ambulatory, non-ambulatory and vertical activity) was measured for 2 h. One week after the last injection, each group received a single injection of morphine (2.5 mg/kg, i.p.) and their locomotor activity was again measured for 2 h (sensitization test, day 14). Results show that SR-48692 alone did not change locomotion. Morphine stimulated locomotor activity, an effect that was stronger on day 7 than on day 1. The two higher doses of SR-48692 attenuated the acute stimulant effect of morphine and prevented the observed increase from day 1 to day 7. The sensitization test on day 14 showed that rats pre-treated with morphine alone displayed significantly stronger ambulatory and vertical activity than vehicle pre-treated rats, a sensitization effect that was attenuated by SR-48692. The present results suggest that end...Continue Reading
References
Sep 1, 1991·Brain Research. Brain Research Reviews·P W Kalivas, J Stewart
Jul 23, 1990·Brain Research·K LaitinenP De Witte
Dec 15, 1990·The Journal of Comparative Neurology·D S Zahm, L Heimer
Sep 1, 1989·Neuropharmacology·V SeutinA Dresse
Oct 9, 1989·Brain Research·P Vezina, J Stewart
Jan 1, 1987·Experimental Brain Research·K B SeroogyJ H Fallon
Dec 9, 1985·Brain Research·P W Kalivas, S Taylor
Jan 16, 1984·Brain Research·P W GlimcherB G Hoebel
Jun 1, 1984·Pharmacology, Biochemistry, and Behavior·P Vezina, J Stewart
Apr 1, 1995·Neuropharmacology·A J Stoessl
Jul 1, 1995·Neuropeptides·R SteinbergP Soubrié
Apr 1, 1994·Neuroscience·R SteinbergP Soubrié
May 19, 1994·Neuroscience Letters·R D Pinnock, G N Woodruff
Jan 1, 1994·Naunyn-Schmiedeberg's Archives of Pharmacology·M PonceletG Le Fur
Mar 3, 1994·European Journal of Pharmacology·A BrouardW Rostene
Jan 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·D GullyA Brouard
Sep 1, 1996·British Journal of Pharmacology·R FernándezJ M Ferrer
Oct 6, 1997·Science·G F Koob, M Le Moal
May 23, 1998·European Journal of Pharmacology·P P RompréJ Moisan
Jul 3, 1999·Trends in Pharmacological Sciences·J P VincentP Kitabgi
Jun 7, 2000·Neuroreport·J C MichaudP Soubrié
Aug 15, 2000·Synapse·P I Johnson, T C Napier
Dec 20, 2000·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·G F Koob, M Le Moal
Jun 22, 2001·Synapse·A L SvingosV M Pickel
Aug 9, 2001·Synapse·M Garzón, V M Pickel
Dec 26, 2001·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Fany PanayiAnne Bérod
Feb 2, 2002·Neuroscience·Y BjijouM Cador
Jun 19, 2002·Naunyn-Schmiedeberg's Archives of Pharmacology·Maud LeonettiMarie-Françoise Suaud-Chagny
Mar 12, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Fannie St-GelaisLouis-Eric Trudeau